Literature DB >> 6253495

Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.

E F Plow, G A Marguerie.   

Abstract

The capacity of epinephrine alone and the combination of low dose epinephrine and ADP to support the binding of fibrinogen to washed human platelets has been examined, 125I-Fibrinogen was bound to epinephrine-stimulated platelets, but 90 min were required to achieve maximal binding at 22 degrees C in contrast to 20 to 30 min with ADP. The overall rate of interaction appeared to reflect the slow binding of fibrinogen to epinephrine-stimulated platelets as opposed to the rate of stimulation of the cell. Divalent ions were required for binding of fibrinogen to epinephrine-stimulated platelets, and both calcium and magnesium supported binding with a prolonged time course. Fibrinogen binding was maximally supported by 20 to 30 microM epinephrine. The combination of low dose epinephrine (5 microM) and low dose ADP (0.5 microM), which acted synergistically to induce platelet aggregation, supported the rapid (10 min) binding of fibrinogen to platelets. With 4 microM epinephrine, more fibrinogen bound per platelet at all ADP doses than with ADP alone. With all the stimuli, saturable binding of fibrinogen to the platelet was observed, and Scatchard plots were linear, yielding very similar apparent association constants. The number of molecules bound per cell was stimulus-dependent, with 30 microM epinephrine inducing the binding of fewer fibrinogen molecules per cell (mean = 20,400) than 10 microM ADP (mean = 35,900) or the combination of 5 microM epinephrine + 0.5 microM ADP (mean = 43,600). The participation of endogenous ADP in fibrinogen binding to epinephrine-stimulated platelets was suggested since enzymes which remove ADP, apyrase, and creatine phosphate/creatine phosphokinase, and the ADP analogue, 2-chloroadenosine, completely inhibited the binding of fibrinogen to the platelet.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253495

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Platelet morphologic changes and fibrinogen receptor localization. Initial responses in ADP-activated human platelets.

Authors:  M E Hensler; M Frojmovic; R G Taylor; R R Hantgan; J C Lewis
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

2.  Use of helper enzymes for ADP removal in infrared spectroscopic experiments: application to Ca2+-ATPase.

Authors:  Man Liu; Eeva-Liisa Karjalainen; Andreas Barth
Journal:  Biophys J       Date:  2005-02-24       Impact factor: 4.033

3.  Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow.

Authors:  A Bonnefoy; Q Liu; C Legrand; M M Frojmovic
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

4.  RGDfK-functionalized gold nanorods bind only to activated platelets.

Authors:  Krystin Zeller Meidell; Ryan Robinson; Adriana Vieira-de-Abreu; Adam J Gormley; Hamidreza Ghandehari; David W Grainger; Robert A Campbell
Journal:  J Biomed Mater Res A       Date:  2016-10-11       Impact factor: 4.396

5.  Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.

Authors:  S R Hanson; F I Pareti; Z M Ruggeri; U M Marzec; T J Kunicki; R R Montgomery; T S Zimmerman; L A Harker
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

6.  Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation.

Authors:  B H Chao; J A Jakubowski; B Savage; E P Chow; U M Marzec; L A Harker; J M Maraganore
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline.

Authors:  E F Plow; G Marguerie
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

8.  Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.

Authors:  S Narumiya; M Okuma; F Ushikubi
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

9.  Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on circulating platelets.

Authors:  H J Avenarius; M Freund; J Deinhardt; H Poliwoda
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

10.  A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.

Authors:  T F Huang; J R Sheu; C M Teng
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.